幼儿急性中毒:Ramathibodi中毒中心10年分析
该研究为回顾性队列研究,利用Ramathibodi中毒中心毒物暴露监测系统数据库,纳入2011年1月至2020年12月泰国小于6岁儿童中毒暴露37,076例。99.8%为意外暴露,94.7%经口摄入;最常见暴露类别为通用化学品(45.8%)、药物(27.5%)和农药(19.0%);总病死率0.3%(114例死亡)。多分类逻辑回归显示新生儿年龄组与死亡独立关联(OR 8.26,95%CI 4.00-17.18),天然毒素暴露与更差结局强关联(OR 5.33,95%CI 2.63-10.80)。作者认为该地区预防策略和临床教育应优先关注高致死性非药物毒物如百草枯、烃类和当地毒蛇。
要点
- 小于6岁儿童中毒总病死率0.3%(114/37,076),主要死因为农药(联吡啶类)、通用化学品(氰化物溶液)和天然毒素(眼镜蛇毒)。
- 新生儿年龄组是与死亡独立关联的因素(OR 8.26,95%CI 4.00-17.18),也是与主要临床效应独立关联的因素(OR 4.59,95%CI 2.27-9.26)。
- 天然毒素暴露与更差结局强关联(OR 5.33,95%CI 2.63-10.80),与主要临床效应强关联(OR 15.46,95%CI 9.04-26.44)。
- 暴露以意外(99.8%)和经口摄入(94.7%)为主,最常见类别为通用化学品45.8%、药物27.5%、农药19.0%。
- 作者认为该地区预防策略和临床教育应优先针对高致死性非药物毒物如百草枯、烃类和当地毒蛇。
适用人群与场景
- 泰国小于6岁儿童,因急性中毒暴露至Ramathibodi中毒中心咨询或就诊的病例,数据来自毒物暴露监测系统数据库2011年1月至2020年12月。
红旗征与不能漏的情况
- 新生儿年龄组暴露:与死亡独立关联(OR 8.26,95%CI 4.00-17.18),与主要临床效应独立关联(OR 4.59,95%CI 2.27-9.26)。
- 天然毒素暴露:与更差结局强关联(OR 5.33,95%CI 2.63-10.80),与主要临床效应强关联(OR 15.46,95%CI 9.04-26.44)。
- 农药(联吡啶类)、通用化学品(氰化物溶液)和天然毒素(眼镜蛇毒)是本队列主要死因。
研究设计与关键结果
- 研究类型:回顾性队列研究,利用Ramathibodi中毒中心毒物暴露监测系统数据库,纳入2011年1月至2020年12月小于6岁儿童中毒暴露37,076例。
- 暴露特征:意外暴露99.8%,经口摄入94.7%;最常见类别为通用化学品45.8%、药物27.5%、农药19.0%。
- 主要结局:总病死率0.3%(114例死亡);主要死因为农药(联吡啶类)、通用化学品(氰化物溶液)和天然毒素(眼镜蛇毒)。
- 回归分析:新生儿年龄组与死亡独立关联(OR 8.26,95%CI 4.00-17.18),与主要临床效应独立关联(OR 4.59,95%CI 2.27-9.26);天然毒素暴露与更差结局强关联(OR 5.33,95%CI 2.63-10.80),与主要临床效应强关联(OR 15.46,95%CI 9.04-26.44)。
- 作者指出该结果与高收入国家不同,高收入国家儿童中毒以药物为主,而本队列以通用化学品和农药为主。
证据类型、等级与局限
- 证据类型:回顾性队列研究,数据来自单中心中毒中心监测数据库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该地区预防策略和临床教育必须优先关注高致死性非药物毒物如百草枯、烃类和当地毒蛇。
- 作者指出新生儿是严重结局和死亡最脆弱的群体。
- 作者指出泰国儿童中毒暴露与高收入国家相比呈现独特区域挑战。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Acute poisoning remains a significant cause of preventable pediatric morbidity worldwide. While epidemiological patterns in high-income countries are well-documented, data from low- and middle-income countries remain distinct. This study aims to identify the epidemiology, toxic agents, and risk factors associated with death in children aged less than six years in Thailand.
METHODS: We conducted a retrospective cohort study utilizing the Ramathibodi Poison Center Toxic Exposure Surveillance System database from January 2011 to December 2020. Multinomial logistic regression was performed to identify independent associations with clinical severity and mortality.
RESULTS: During the study period, 37,076 pediatric exposures were evaluated. The majority of exposures were unintentional (99.8%) and occurred via oral ingestion (94.7%). The most common exposure categories were general-purpose chemicals (45.8%), medications (27.5%), and pesticides (19.0%). Overall mortality was 0.3% (114 deaths). The leading causes of death were pesticides (bipyridyl), general-purpose chemicals (cyanide solution), and natural toxins (cobra venom). Regression analysis identified the newborn age group as a significant independent association of mortality (odds ratio 8.26, 95% CI 4.00-17.18) and major clinical effects (odds ratio 4.59, 95% CI 2.27-9.26). Exposure to natural toxins was strongly associated with worse outcomes (odds ratio 5.33, 95% CI 2.63-10.80) and major effects (odds ratio 15.46, 95% CI 9.04-26.44).
DISCUSSION: Our finding differs from that in high-income countries. While pediatric poisoning in high-income countries is predominantly driven by pharmaceuticals, our study population was most frequently exposed to general-purpose chemicals and pesticides. Significantly, newborns were identified as the most vulnerable group for severe outcomes and death.
CONCLUSIONS: Pediatric poisoning exposures in Thailand present unique regional challenges compared to high-income nations. Preventive strategies and clinical education in this region must prioritize the mitigation of highly lethal, non-pharmaceutical agents such as paraquat, hydrocarbons, and local venomous species.
参考来源
- Tongpoo A, Sanprasert K, Ariyaviraplorn N, et al. Acute poisoning in young children: a 10-year analysis from Ramathibodi Poison Center. Clin Toxicol (Phila). 2026. PMID: 42490079. doi:10.1080/15563650.2026.2691834
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。